Patents by Inventor Steve Fong

Steve Fong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
    Patent number: 8431563
    Abstract: The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: April 30, 2013
    Assignee: Amgen Inc.
    Inventors: Kate Ashton, Michael David Bartberger, Yunxin Bo, Marian C. Bryan, Michael Croghan, Christopher Harold Fotsch, Clarence Henderson Hale, Roxanne Kay Kunz, Longbin Liu, Nobuko Nishimura, Mark H. Norman, Lewis Dale Pennington, Steve Fong Poon, Markian Myroslaw Stec, David Joseph St. Jean, Jr., Nuria A. Tamayo, Christopher Michael Tegley, Kevin Chao Yang
  • Calcium receptor modulating agents
    Patent number: 8349831
    Abstract: The present invention relates generally to compounds represented in Formula I, pharmaceutical compositions comprising them and methods of treating of diseases or disorders related to the function of the calcium sensing receptor. The invention also relates to processes for making such compounds and to intermediates useful in these processes.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: January 8, 2013
    Assignee: Amgen Inc.
    Inventors: Thomas S. Coulter, Adam James Davenport, Christopher H. Fotsch, Chiara Ghiron, Paul E. Harrington, Michael Gerard Kelly, Steve Fong Poon, Andrew Tasker, Ning Xi, Qing Ping Zeng
  • COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES
    Publication number: 20120225854
    Abstract: The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: August 23, 2011
    Publication date: September 6, 2012
    Applicant: AMGEN INC.
    Inventors: Kate Ashton, Michael David Bartberger, Yunxin Bo, Marian C. Bryan, Michael Croghan, Christopher Harold Fotsch, Clarence Henderson Hale, Roxanne Kay Kunz, Longbin Liu, Nobuko Nishimura, Mark H. Norman, Lewis Dale Pennington, Steve Fong Poon, Markian Myroslaw Stec, David Joseph St. Jean, JR., Nuria A. Tamayo, Christopher Michael Tegley, Kevin Chao Yang
  • Calcium receptor modulating agents
    Publication number: 20080221101
    Abstract: The present invention relates generally to compounds represented in Formula I, pharmaceutical compositions comprising them and methods of treating of diseases or disorders related to the function of the calcium sensing receptor. The invention also relates to processes for making such compounds and to intermediates useful in these processes.
    Type: Application
    Filed: October 25, 2007
    Publication date: September 11, 2008
    Applicant: Amgen Inc.
    Inventors: Thomas S. Coulter, Adam James Davenport, Christopher H. Fotsch, Chiara Ghiron, Paul E. Harrington, Michael Gerard Kelly, Steve Fong Poon, Andrew Tasker, Ning Xi, Qing Ping Zeng
  • Shallow trench isolation (STI) with trench liner of increased thickness
    Publication number: 20070267715
    Abstract: Improved shallow trench isolation (STI) techniques are provided for semiconductor devices. For example, in accordance with an embodiment of the present invention, an integrated circuit includes a substrate, a first trench in the substrate, and a second trench in the substrate. A first silicon dioxide liner substantially lines the first trench. A second silicon dioxide liner substantially lines the second trench, wherein the second silicon dioxide liner has a thickness greater than a thickness of the first silicon dioxide liner. A silicon nitride liner is on the first silicon dioxide liner in the first trench but not on the second silicon dioxide liner in the second trench. A dielectric material fills the first and second trenches.
    Type: Application
    Filed: May 18, 2006
    Publication date: November 22, 2007
    Inventors: Sunil Mehta, Stewart Logie, Steve Fong
  • Command reordering for out of order bus transfer
    Patent number: 6405267
    Abstract: A system and method for increasing effective bus bandwidth in communicating with a graphics device. Graphics commands and associated parameters are written into a contiguous region of system memory and transmitted in a weakly ordered fashion over a bus to a graphics device. The graphics device reorders the incoming data into the same order as which the data was written into the contiguous region of system memory, thereby allowing the use of order dependent encoded commands with the weakly ordered bus interface.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: June 11, 2002
    Assignee: S3 Graphics Co., Ltd.
    Inventors: Randy X. Zhao, Chien-Te Ho, Steve Fong